Bristol and Bath spin-out company, Ceryx Medical, has appointed Chas Taylor as Chairman. He brings with him decades of experience in developing and leading medical device companies. Ceryx are developing an evolutionary technology that could significantly change the way patients with serious heart problems are treated and this new appointment will help drive the acceleration of the technology towards clinic.
https://news.lifesciencenewswire.com/newsroom/ceryx-medical-appoints-chas-taylor-as-chairman